Hualan Biological Engineering, Inc.

Multiple major Chinese vaccine manufacturers are expecting annual profits to have slumped in 2024, as fiercer competition, destocking at vaccination clinics and a slowing Chinese economy all weigh on

The strict "COVID Zero" policies in China may have had one unintended consequence: weakened immune systems that could be leading to outbreaks of other infectious diseases, notably influenza. Low rates